Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2000 Apr;129(7):1490-6.
doi: 10.1038/sj.bjp.0703226.

Effects of inhibitors of small- and intermediate-conductance calcium-activated potassium channels, inwardly-rectifying potassium channels and Na(+)/K(+) ATPase on EDHF relaxations in the rat hepatic artery

Affiliations

Effects of inhibitors of small- and intermediate-conductance calcium-activated potassium channels, inwardly-rectifying potassium channels and Na(+)/K(+) ATPase on EDHF relaxations in the rat hepatic artery

D A Andersson et al. Br J Pharmacol. 2000 Apr.

Abstract

1. In the rat hepatic artery, the SK(Ca) inhibitors UCL 1684 (300 nM) completely blocked, and scyllatoxin (1 microM) and d-tubocurarine (100 microM) partially inhibited EDHF relaxations when each of them was combined with charybdotoxin (300 nM). 2. The IK(Ca) inhibitors clotrimazole (3 microM) and 2-chlorophenyl-bisphenyl-methanol (3 microM) strongly depressed EDHF relaxations when each of them was combined with apamin (300 nM). The cytochrome P450 mono-oxygenase inhibitor ketoconazole (10 microM) had no effect in the presence of apamin. 3. Ciclazindol (10 microM), which abolishes EDHF relaxations in the presence of apamin, almost completely prevented the calcium ionophore (A23187) stimulated (86)Rb(+) influx via the Gardos channel (IK(Ca)) in human erythrocytes. 4. The Na(+)/K(+) ATPase inhibitor ouabain (500 microM) and the K(IR) blocker Ba(2+) (30 microM) neither alone nor in combination inhibited EDHF relaxations. Ba(2+) was also without effect in the presence of either apamin or charybdotoxin. 5. In contrast to EDHF, an increase in extracellular [K(+)] from 4.6 mM to 9.6, 14.6 and 19.6 mM inconsistently relaxed arteries. In K(+)-free physiological salt solution, re-admission of K(+) always caused complete and sustained relaxations which were abolished by ouabain but unaffected by Ba(2+). 6. The present study provides pharmacological evidence for the involvement of SK(Ca) and IK(Ca) in the action of EDHF in the rat hepatic artery. Our results are not consistent with the idea that EDHF is K(+) activating Na(+)/K(+) ATPase and K(IR) in this blood vessel.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Effects of SKCa inhibitors on EDHF relaxations induced by acetylcholine in the presence of Nω-nitro-L-arginine (300 μM) and indomethacin (10 μM) in arteries contracted by phenylephrine. The SKCa blockers UCL 1684 (n=5), scyllatoxin (ScTx, n=6) and d-tubocurarine (d-TC, n=6) were each combined with charybdotoxin (ChTx) and the effect of these combinations on EDHF was compared to that of charybdotoxin alone (n=10). At this concentration (300 nM), charybdotoxin is without any effect on EDHF relaxations. Data are presented as means±s.e.mean.
Figure 2
Figure 2
Effect of IKCa inhibitors on EDHF relaxations induced by acetylcholine in the presence of Nω-nitro-L-arginine (300 μM) and indomethacin (10 μM) in arteries contracted by phenylephrine. The IKCa blockers clotrimazole (CLT) and 2-chlorophenyl-bisphenyl-methanol (C23) were each combined with apamin and the effect of these combinations on EDHF was compared to that of apamin alone. At this concentration (300 nM), apamin is without any effect on EDHF relaxations. Data are presented as means±s.e.mean of six experiments.
Figure 3
Figure 3
Effects of K+ channel inhibitors on calcium ionophore stimulated 86Rb+ influx in human erythrocytes. The K+ channel inhibitors iberiotoxin (IbTx), apamin (Apa), charybdotoxin (ChTx), ciclazindol (Cz), clotrimazole (CLT) and 2-chlorophenyl-bisphenyl-methanol (C23) and the cytochrome P450 mono-oxygenase inhibitor ketoconazole (KEC) were present 85 min before erythrocytes were stimulated for 5 min by A23187 and Ca2+. Data are expressed as percentage of 86Rb+ influx in the absence of test drugs (control) and are presented as means±s.e.mean of six experiments (all from different individuals). Asterisks denote a statistically significant difference from control values (P<0.05).
Figure 4
Figure 4
Effects of ouabain and Ba2+ on EDHF relaxations induced by acetylcholine in the presence of Nω-nitro-L-arginine (300 μM) and indomethacin (10 μM) in arteries contracted by phenylephrine. The effect of ouabain and Ba2+ either alone or combined was examined. Control denotes EDHF relaxations in the absence of these drugs. Data are presented as means±s.e.mean of 7–9 experiments.
Figure 5
Figure 5
Traces showing differences between K+ and EDHF relaxations in hepatic arteries contracted by phenylephrine (PhE) in the presence of Nω-nitro-L-arginine (300 μM) and indomethacin (10 μM). Arterial segments were first exposed to acetylcholine (ACh) to demonstrate EDHF relaxations in a physiological salt solution with a normal K+ content (4.6 mM KCl). After a washout period of 30 min, the relaxant effect of increased extracellular K+ concentrations (from 4.6 mM to 9.6, 14.6 and 19.6 mM) was recorded to see whether K+ could mimic EDHF in these arterial segments. Dashed line indicates the basal tension level before addition of phenylephrine. Upper panel K+ failed to relax an arterial segment in which EDHF caused relaxation. Lower panel Although K+ could relax another arterial segment the relaxation was transient and partial in contrast to the EDHF relaxation.
Figure 6
Figure 6
Effects of ouabain and Ba2+ on relaxation evoked by K+ in the presence of Nω-nitro-L-arginine (300 μM) and indomethacin (10 μM) in arteries contracted by phenylephrine. Preparations were incubated with either ouabain or Ba2+ or vehicle (control) for 30 min in K+-free physiological salt solution before re-admission of K+. Data are presented as means±s.e.mean of 6–9 experiments.

References

    1. ANDERSSON D.A., ZYGMUNT P.M., HÖGESTÄTT E.D. Pharmacological evidence for the involvement of IKCa and SKCa in EDHF-mediated relaxation of the rat hepatic artery. Br. J. Pharmacol. 1998;125:9P.
    1. AUGUSTE P., HUGUES M., GRAVÉ B., GESQUIÈRE J.-C., MAES P., TARTAR A., ROMEY G., SCHWEITZ H., LAZDUNSKI M. Leiurotoxin I (Scyllatoxin), a peptide ligand for Ca2+-activated K+ channels. J. Biol. Chem. 1990;265:4753–4759. - PubMed
    1. BENTON D.C.H., ROXBURGH C.J., GANELLIN C.R., SHINER M.A.R., JENKINSON D.H. Differences in the actions of some blockers of the calcium-activated potassium permeability in mammalian red cells. Br. J. Pharmacol. 1999;126:169–178. - PMC - PubMed
    1. BOLZ S.-S., DE WIT C., POHL U. Endothelium-derived hyperpolarizing factor but not NO reduces smooth muscle Ca2+ during acetylcholine-induced dilation of microvessels. Br. J. Pharmacol. 1999;128:124–134. - PMC - PubMed
    1. BRUGNARA C., ARMSBY C.C., DE FRANCESCHI L., CREST M., EUCLAIRE M.-F., ALPER S.P. Ca2+-activated K+ channels of human and rabbit erythrocytes display distinctive patterns of inhibition by venom peptide toxins. J. Membr. Biol. 1995a;147:71–82. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources